Evolus Inc
NASDAQ:EOLS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Evolus Inc
NASDAQ:EOLS
|
US |
|
Lifetime Brands Inc
NASDAQ:LCUT
|
US |
|
California Resources Corp
NYSE:CRC
|
US |
|
Repay Holdings Corp
NASDAQ:RPAY
|
US |
|
Anika Therapeutics Inc
NASDAQ:ANIK
|
US |
|
Full Truck Alliance Co Ltd
NYSE:YMM
|
CN |
|
Toronto-Dominion Bank
TSX:TD
|
CA |
|
Diageo PLC
LSE:DGE
|
UK |
|
Logitech International SA
SIX:LOGN
|
CH |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
US |
|
Wayfair Inc
NYSE:W
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
|
Globe Life Inc
NYSE:GL
|
US |
|
B
|
Banco Itau Chile
SGO:ITAUCL
|
CL |
|
AZZ Inc
NYSE:AZZ
|
US |
|
Adapthealth Corp
NASDAQ:AHCO
|
US |
|
8
|
8x8 Inc
NASDAQ:EGHT
|
US |
Bankruptcy Probability
Evolus Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Evolus Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Evolus Inc
NASDAQ:EOLS
|
424.7m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
982.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
558B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
217.2B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
226.2B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
286.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
224.1B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Evolus Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Evolus Inc has total debt of 156.4m USD. This includes both short-term (0 USD) and long-term (156.4m USD) debt.
You can find a full breakdown on its Balance Sheet.
